KMDA Kamada
P/E
20.42
Forward P/E
16.53
Price/Sales
2.334
Beta
0.132
Div Yield
0.022%
Market Cap
--
Company Analysis
Latest News
Rabies Surge Sends Kamada Shares to New Heights — But Can a Public Health Scare Sustain a 56% Gap to the Price Target?
Shares of Kamada Ltd. surged 8.7% to $9.62 as investors bet that a genuine U.S. public health crisis could translate into durable revenue upside for a $500...
🟢 Kamada is trading 8.7% up in pre-market on stronger U.S. rabies-treatment demand
Kamada is trading 8.7% up now at $9.62 as investors respond to increased U.S. rabies-treatment demand and the company’s confirmation of sufficient KedRAB...
🟢 Kamada is trading 5.7% up today after confirming sufficient KedRAB inventory and manufacturing capacity
Kamada is trading 5.7% up at $8.65 after confirming sufficient KedRAB inventory and manufacturing capacity amid increased U.S. demand. - The update followed a...
🟢 Kamada is trading 5.4% up today, possibly ahead of H.C. Wainwright presentation
Kamada is trading at $8.35, up 5.43%, possibly reflecting investor positioning ahead of CEO Amir London’s scheduled September 15 presentation at the H.C....